Pfizer EPS - Earnings per Share 2012-2026 | PFE

Pfizer earnings per share (EPS) for the twelve months ending March 31, 2026 was $1.31, a 5.07% decline year-over-year.

  • Pfizer EPS for the quarter ending March 31, 2026 was $0.47, a 9.62% decline year-over-year.
  • Pfizer 2025 annual EPS was $1.36, a 3.55% decline from 2024.
  • Pfizer 2024 annual EPS was $1.41, a 281.08% increase from 2023.
  • Pfizer 2023 annual EPS was $0.37, a 93.24% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Pfizer EPS - Earnings per Share 2012-2026 | PFE

  • Pfizer EPS for the quarter ending March 31, 2026 was $0.47, a 9.62% decline year-over-year.
  • Pfizer 2025 annual EPS was $1.36, a 3.55% decline from 2024.
  • Pfizer 2024 annual EPS was $1.41, a 281.08% increase from 2023.
  • Pfizer 2023 annual EPS was $0.37, a 93.24% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B